Abstract Cannabis has been used for decades as a palliative therapy in the treatment of cancer. This is because of its beneficial effects on the pain and nausea that patients
Abstract As countries adopt more permissive cannabis policies, it is increasingly important to identify strategies that can reduce the harmful effects of cannabis use. This study aimed to determine if
Please use this link to access this publication: https://onlinelibrary.wiley.com/doi/epdf/10.1002/j.1532-2149.2013.00445.x Abstract Background: Peripheral neuropathic pain (PNP) associated with allodynia poses a significant clinical challenge. The efficacy of Δ(9) -tetrahydrocannabinol/cannabidiol (THC/CBD) oromucosal spray, a
Please use this link to access this publication: https://www.epilepsybehavior.com/article/S1525-5050(19)31116-3/fulltext Abstract Rationale: The rationale of this study was to assess occurrence of withdrawal symptoms induced by abrupt cessation of cannabidiol (CBD) after prolonged
Please follow this link to access this publication: https://www.sciencedirect.com/science/article/abs/pii/S1525505019301167 Abstract Treatment-resistant epilepsy (TRE) is associated with low quality of life (QOL). Cannabidiol (CBD) may improve QOL, but it is unclear
Abstract Rationale: Treatment with a highly purified oral solution of cannabidiol (CBD), derived from the plant Cannabis sativa L., demonstrated some evidence of central nervous system (CNS)-related adverse events in patients
Abstract Cannabis sativa L. (Cannabis) and its bioactive compounds, including cannabinoids and non-cannabinoids, have been extensively studied for their biological effects in recent decades. Cannabidiol (CBD), a major non-intoxicating cannabinoid in Cannabis,
Recently, an increasing number of advertisements have appeared online highlighting various CBD products, typically gummies, endorsing benefits such as pain relief, improved sleep, and lessened anxiety. Unfortunately, to the consumer
Abstract BACKGROUND AND PURPOSE The cannabinoid 1 (CB1) receptor inverse agonists/antagonists, rimonabant (SR141716, SR) and AM251, produce nausea and potentiate toxin-induced nausea by inverse agonism (rather than antagonism) of the
According to the American Thyroid Association (ATA), an estimated 20 million Americans have some form of thyroid disease and an estimated 60% are unaware of their condition. Women are more
